A detailed history of Great Point Partners LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Great Point Partners LLC holds 1,326,234 shares of DVAX stock, worth $16.1 Million. This represents 6.83% of its overall portfolio holdings.

Number of Shares
1,326,234
Previous 2,374,000 44.14%
Holding current value
$16.1 Million
Previous $26.7 Million 44.58%
% of portfolio
6.83%
Previous 7.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.05 - $11.61 $10.5 Million - $12.2 Million
-1,047,766 Reduced 44.14%
1,326,234 $14.8 Million
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $11.9 Million - $14 Million
1,109,080 Added 87.68%
2,374,000 $26.7 Million
Q1 2024

May 15, 2024

BUY
$11.7 - $14.98 $14.8 Million - $18.9 Million
1,264,920 New
1,264,920 $15.7 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.54B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.